Axoltis pharma is a biopharmaceutical company dedicated to develop first-in-class disease-modifying drugs to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.
Location: France, Auvergne-Rhône-Alpes, Lyon
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Angelor | angelor.bi... |